[Combined treatment of voiding disorders in women with m-cholinolytic and alpha 1-adrenoblocker].
The drug spasmex (trospium chloride) having an m-cholinolytic and myotropic spasmolytic action has been used for treatment of enuresis in women with imperative voiding syndrome. Spasmex was given in combination with alpha 1-adrenoblockers to 20 women. The clinical picture was assessed with the original table. Urodynamic alterations were registered by means of home uroflowmeter. Clinical parameters improved 2 times after 4 weeks of the treatment. Mean effective capacity of the urinary bladder increased by 25%. Spasmex in combination with terasozine was well tolerated and had no side effects.
Danilov
V V
VV
Vol'nykh
I Iu
IIu
Abdullaeva
C K
CK
Danilova
T I
TI
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage*; D001561:Benzilates; D005260:Female; D006801:Humans; D008875:Middle Aged; D009662:Nortropanes / Q000008:administration & dosage*; D010276:Parasympatholytics / Q000008:administration & dosage*; D011224:Prazosin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D014463:Ultrasonography; D001743:Urinary Bladder / Q000000981:diagnostic imaging / Q000473:pathology; D014549:Urinary Incontinence / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D014563:Urodynamics / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D001561:Benzilates; D009662:Nortropanes; D010276:Parasympatholytics; C003330:trospium chloride; C041226:Terazosin; D011224:Prazosin